Literature DB >> 27383144

Success Rates of Conventional Versus Endoscope-Assisted Probing for Congenital Nasolacrimal Duct Obstruction in Children 12 Years and Younger.

Alicia Galindo-Ferreiro, Patricia Akaishi, Augusto Cruz, Rajiv Khandekar, Saif Dossari, Mohammed Dufaileej, Alberto Galvez-Ruiz, Silvana Schellini.   

Abstract

PURPOSE: To compare the success rates for congenital nasolacrimal duct obstruction (CNLDO) treated with conventional probing versus endoscope-assisted probing.
METHODS: A retrospective nonrandomized comparison of the success rates in children (0 to 12 years) with CNLDO who underwent conventional probing or endoscope-assisted probing. Success was defined as absence of tearing or negative fluorescein dye disappearance test. Stent was evaluated.
RESULTS: A total of 270 patients with CNLDO comprised the study population. The mean age was 37 months in the conventional probing group and 48.5 months in the endoscope-assisted probing group. The subjective and objective success rates were 76.1% and 75.9%, respectively, in the conventional probing group and 95.7% and 95.7%, respectively, in the endoscope-assisted probing group. The success rates were higher for both methods in the endoscope-assisted probing group (P < .005). The success rate decreased in older children in the conventional probing group (100% < 6 months; 62.5% > 48 months) and remained stable in the endoscope-assisted probing group (100% < 6 months; 97% > 48 months). Stent did not improve success.
CONCLUSIONS: Endoscope-assisted probing increased success in older children and children with bilateral obstruction. [J Pediatr Ophthalmol Strabismus. 2016;53(5):292-299.]. Copyright 2016, SLACK Incorporated.

Entities:  

Mesh:

Year:  2016        PMID: 27383144     DOI: 10.3928/01913913-20160610-02

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  1 in total

1.  Endoscopy in the field of oculo-facial plastic surgery.

Authors:  Mohsen Bahmani Kashkouli; Bijan Beigi
Journal:  J Curr Ophthalmol       Date:  2018-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.